RESUMO
5-Thio-D-glucose effectively killed hypoxic mastocytoma cells of DBA/2J mice, whereas it merely suppressed the growth of oxic cells. This specific toxicity suggested that 5-thio-D-glucose may be a useful adjuvant to radiotherapy by eliminating hypoxic protection.
Assuntos
Glucose/análogos & derivados , Oxigênio , Sarcoma Experimental/tratamento farmacológico , Animais , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Sobrevivência Celular/efeitos dos fármacos , Glucose/farmacologia , Hipóxia , Sarcoma de Mastócitos/tratamento farmacológico , Camundongos , Camundongos Endogâmicos DBA , Compostos de Sulfidrila/farmacologiaRESUMO
Three novel heterocyclic compounds, mycalamide-A and -B and onnamide, were isolated from Mycale sp. and Theonella sp. sponges collected in New Zealand and Okinawan waters. Each exhibited potent in vitro toxicity and in vivo efficacy against murine and human tumor cells. Concentrations of each that inhibited replication of cultured murine lymphoma P388 cells by 50% were 5 nM or less. Mycalamide-A and -B were also potent inhibitors of HL-60, HT-29, and A549 human tumor cell replication (50% inhibitory concentration less than 5 nM), while values for onnamide were greater (50% inhibitory concentrations between 25 and 200 nM). Mycalamide-A (10 micrograms/kg) and -B (2.5 micrograms/kg) were moderately active against P388 leukemia (increase in life span, approximately 50%), while onnamide was inactive (40 micrograms/kg; increase in life span, 15%). Mycalamide-A was also active against B16 melanoma, Lewis lung carcinoma, M5076 ovarian sarcoma, colon 26 carcinoma, and the human MX-1, CX-1, and Burkitt's lymphoma tumor xenografts. Mechanism of action studies indicate that the three agents inhibited protein synthesis. For example, after 1-h exposures to 20 nM mycalamide-A and -B, the rates of [3H]leucine incorporation into acid-precipitable material of cultured P388 cells were inhibited 54 and 99%, while the effects on incorporation of [3H]uridine and [3H]thymidine were less. The relative effects of 20 to 2000 nM mycalamide-A on protein, RNA, and DNA synthesis were consistent with those observed during exposure of P388 cells to 1 microM emetine, a known inhibitor of protein synthesis. Also, the three agents inhibited translation of RNA into protein in a cell-free lysate of rabbit reticulocytes. Although mycalamide-A disrupted DNA metabolism, the agent apparently did not intercalate into DNA, and a mixture of four deoxynucleosides (250 microM each) did not decrease the antiproliferative effects of the agent. Collectively, these data indicate that this class of compounds represents novel antitumor agents which should be further evaluated to define their potential.
Assuntos
Antineoplásicos/farmacologia , Linfoma de Burkitt/tratamento farmacológico , Leucemia P388/tratamento farmacológico , Leucemia Experimental/tratamento farmacológico , Toxinas Marinhas/farmacologia , Melanoma Experimental/tratamento farmacológico , Piranos/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Fenômenos Químicos , Química , DNA de Neoplasias/biossíntese , DNA de Neoplasias/efeitos dos fármacos , Feminino , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos DBA , Camundongos Nus , Transplante de Neoplasias , Biossíntese de Proteínas , RNA Mensageiro/biossíntese , RNA Mensageiro/efeitos dos fármacos , RNA Neoplásico/biossíntese , RNA Neoplásico/efeitos dos fármacos , Células Tumorais Cultivadas/efeitos dos fármacosRESUMO
The effect of 5-thio-D-glucose on oxic and hypoxic V79-171 Chinese hamster cells was studied in vitro with single cells and multicell spheroids. At concentrations that were not toxic to oxic cells, this compound killed hypoxic cells with a D0 of 1 hr with a 5 mM concentration and more rapidly at 10 mM beginning 2 hr after incubation at 37 degrees. 5-Thio-D-glucose also sensitized hypoxic cells to radiation and protected oxic cells from radiation damage. Multicell spheroids irradiated after incubation with the compound demonstrated increased radiosensitivity, although the relative contribution of cytotoxicity and hypoxic cell sensitization could not be evaluated. Spheroid reoxygenation by decreased cell respiration was determined not to be a contributing factor, suggesting that the spheroid-sensitizing effect was due to drug effects on hypoxic cells. The dramatic increase in multicell spheroid radiosensitivity that resulted from treatment with 5-thio-D-glucose suggests that this compound may be used to increase the effectiveness of radiotherapy by eliminating hypoxic protection.
Assuntos
Sobrevivência Celular/efeitos dos fármacos , Glucose/análogos & derivados , Hipóxia , Oxigênio , Sobrevivência Celular/efeitos da radiação , Células Cultivadas , Glucose/farmacologia , Consumo de Oxigênio/efeitos dos fármacos , RadiossensibilizantesRESUMO
A new cytotoxic acridine alkaloid that exhibited antitumor activity in vivo was isolated from a marine Dercitus species sponge collected at a depth of 160 m in the Bahamas. This violet alkaloid, designated dercitin, inhibited the proliferation of cultured murine and human leukemia, lung, and colon tumor cells at nM concentrations (IC50 values of 63-150 nM) and prolonged the life of mice bearing ascitic P388 tumors (%T/C = 170, 5 mg/kg, i.p., QD1-9). Dercitin was also active against i.p. B16 melanoma and modestly inhibited the growth of s.c. Lewis lung carcinoma on the same schedule. DNA blocked the antiproliferative effects of the agent in culture, and incorporation studies indicated that dercitin disrupted DNA and RNA synthesis with less effects on protein synthesis, similar to the effects of known DNA intercalators. After 1-h exposure to 400 nM dercitin, the rates of incorporation of [3H]uridine, [3H]thymidine, and [3H]leucine by cultured P388 cells were inhibited 83, 61, and 23%, respectively. Equilibrium dialysis indicated that dercitin bound calf thymus DNA with an affinity of 3.1 microM and maximal binding of 0.20 mol dercitin/mol base pair. Binding involved intercalation as evidenced by ability to relax supercoiled phi X174 DNA (half maximal concentration for dercitin relaxation was 36 nM). The effects of dercitin on DNA mobility were reversible, and complete relaxation of DNA with topoisomerase I in the presence of dercitin followed by phenol extraction resulted in the appearance of supercoiled DNA. Dercitin, at microM concentrations, had a small effect in the K+-sodium dodecyl sulfate assay using cultured P388 cells, suggesting minimal inhibition of topoisomerase activity. But, dercitin completely inhibited DNA polymerase I/DNase nick translation of DNA at 1 microM. Relaxation of DNA at a given concentration was greater than inhibition of nick translation suggesting that the effects of dercitin on enzyme activity were secondary to changes in DNA conformation. Results indicate that dercitin is a new marine natural product that probably exerts its biological effects through intercalation into nucleic acids.
Assuntos
Alcaloides/farmacologia , Carcinoma/tratamento farmacológico , Leucemia P388/tratamento farmacológico , Leucemia Experimental/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Melanoma Experimental/tratamento farmacológico , Alcaloides/metabolismo , Animais , Carcinoma/metabolismo , Divisão Celular/efeitos dos fármacos , DNA Topoisomerases Tipo II/metabolismo , DNA de Neoplasias/biossíntese , DNA de Neoplasias/efeitos dos fármacos , DNA Super-Helicoidal/efeitos dos fármacos , Resistência a Medicamentos , Leucemia P388/metabolismo , Neoplasias Pulmonares/metabolismo , Masculino , Melanoma Experimental/metabolismo , Camundongos , Biossíntese de Proteínas/efeitos dos fármacos , RNA Neoplásico/biossíntese , RNA Neoplásico/efeitos dos fármacosRESUMO
A-84441, a potent new antitumor quinolone, was active in vitro and in vivo against murine and human tumors. A-84441, a prodrug, was comparable in potency to the parent compound with an IC50 range of 0.03-0.49 microgram/ml against a panel of murine and human tumor cell lines. The parent compound bound mammalian DNA in a magnesium-dependent manner and caused inhibition of DNA and RNA synthesis. A-84441 produced a significant increased life span and cures in three lines of i.p. implanted murine tumors. A-84441 was active against seven of nine solid tumors including s.c. murine tumors and human tumor xenografts. The compound appeared to be more active when administered i.v. compared to i.p. injection. Antitumor efficacy was little effected by treatment schedule, although multiple divided dosing was generally more effective than single dose treatment. A-84441 was over 10-fold-more active against murine leukemic cells than against normal murine bone marrow cells. The acute toxicity of A-84441 following single or multiple dosing ranged between 11 and 50 mg/kg dependent on schedule of administration when given by i.v. or i.p. route. The agent had no apparent toxicity or efficacy when administered p.o.
Assuntos
Antineoplásicos/farmacologia , Pró-Fármacos/farmacologia , Quinolonas/farmacologia , Animais , Antineoplásicos/metabolismo , Antineoplásicos/toxicidade , Medula Óssea/efeitos dos fármacos , DNA de Neoplasias/metabolismo , Esquema de Medicação , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Humanos , Dose Letal Mediana , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos DBA , Transplante de Neoplasias , Neoplasias/tratamento farmacológico , Neoplasias Experimentais/tratamento farmacológico , Pró-Fármacos/metabolismo , Pró-Fármacos/toxicidade , Quinolonas/metabolismo , Quinolonas/toxicidade , Transplante Heterólogo , Células Tumorais Cultivadas/efeitos dos fármacosRESUMO
The influence of the radiosensitizer misonidazole on the effectiveness of several alkylating agents and cis-platinum against advanced solid murine tumors was investigated. Tumor regrowth delay, frequency of tumor regressions, and animal life span were used to evaluate misonidazole in combination with cyclophosphamide, L-phenylalanine mustard, 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl)-1-nitrosourea, aziridinyl-benzoquinone, and cis-platinum. In the advanced M5076 ovarian carcinoma, misonidazole enhanced the activity of cyclophosphamide, L-phenylalanine mustard, 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl)-1-nitrosourea, and aziridinyl benzoquinone, but not cis-platinum. In early B16 melanoma, misonidazole plus cyclophosphamide was no more effective than cyclophosphamide alone. In advanced Lewis lung carcinoma, misonidazole enhanced the antitumor activity of cyclophosphamide but not 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl)-1-nitrosourea. Misonidazole, at 1000 mg/kg, increased the antitumor effectiveness of L-phenylalanine mustard and cyclophosphamide in M5076 tumors by factors of 2.2 and 1.8, but caused only a 1.2- and 1.3-fold increase in the myelotoxicity of these agents as determined by spleen colony assay of normal bone marrow. Misonidazole also increased the toxicity of cyclophosphamide and L-phenylalanine mustard in non-tumor-bearing mice but to a lesser degree than it enhanced antitumor activity. These results indicate that misonidazole is capable of enhancing the effects not only of ionizing radiation but of alkylating agents as well.
Assuntos
Alquilantes/administração & dosagem , Benzoquinonas , Misonidazol/administração & dosagem , Neoplasias Experimentais/tratamento farmacológico , Nitroimidazóis/administração & dosagem , Animais , Aziridinas/administração & dosagem , Cicloexenos , Ciclofosfamida/administração & dosagem , Quimioterapia Combinada , Feminino , Melfalan/administração & dosagem , Camundongos , Quinonas/administração & dosagem , Semustina/administração & dosagemRESUMO
Transplantable murine neuroblastoma C 1300 was studied ultrastructurally at varying time intervals ranging from 2 hours to 40 days before and after X-irradiation. Following X-irradiation, 2000 and 4000 rads in a single dose, the uniformly small tumor cells became progressively enlarged multinucleated and degenerated, starting at one to two days. At five to seven days, the uni- and multinucleated giant cells predominated over the small tumor cells, while the giant cells progressively disappeared therafter and the small tumor cells predominated over the giant cells at 10 to 14 days. The giant cells contained abundant subcellular organelles and the X-irradiated tumor cells apparently continued to produce the organelles until they degenerated. Two types of cytoplasmic particles, intracisternal A and bar-shaped, were observed in the tumor cells. The intracisternal A particles occurred in almost all non-irradiated tumor cells though their number varied considerably from cell to cell, while they were observed less frequently in the radiation-induced giant cells probably due to a dilution effect rather than an actual numerical decrease. The bar-shaped particles, hitherto undescribed in the neuroblastoma, were 23 nm in diameter, variable in length and occasionally tubular. They occurred only in degenerating cells regardless of X-irradiation but were encountered more frequently in irradiated tumors than in non-irradiated ones. It is suggested that they may represent an unknown degenerative product of cytoplasm and/or nucleus rather than virus particles, despite their morphological resemblance to certain virus particles.
Assuntos
Corpos de Inclusão/efeitos da radiação , Neuroblastoma/radioterapia , Animais , Complexo de Golgi/efeitos da radiação , Complexo de Golgi/ultraestrutura , Corpos de Inclusão/ultraestrutura , Camundongos , Mitocôndrias/efeitos da radiação , Mitocôndrias/ultraestrutura , Neoplasias Experimentais/radioterapia , Neoplasias Experimentais/ultraestrutura , Neuroblastoma/ultraestruturaRESUMO
A series of novel, pseudo-symmetrical difluoroketones which are highly potent inhibitors of the HIV-1 protease (IC50 = 1.55-0.02 nM) were synthesized. These compounds also possess good antiviral activity by inhibition of the cytopathic effect of HIV-13B in MT-4 cells in vitro.
Assuntos
Antivirais/farmacologia , Inibidores da Protease de HIV/farmacologia , Cetonas/farmacologia , Antivirais/química , Fenômenos Químicos , Físico-Química , Inibidores da Protease de HIV/química , Cetonas/química , Estrutura Molecular , Proteínas Recombinantes/antagonistas & inibidores , Relação Estrutura-AtividadeRESUMO
The effect of WR 2721 on the response of tumors to radiation, antineoplastic alkylating drugs, and DNA binding agents was evaluated and compared to the degree of normal tissue protection provided by WR 2721 against these agents. WR 2721 administered to mice bearing P388 leukemia or Lewis lung carcinoma was found to reduce the radiosensitivity of the leukemia and lung tumor by dose modifying factors of 1.4 and 1.3, respectively. WR 2721 protected bone marrow, intestine, and skin from radiation by factors of 1.9, 1.5, and 1.8. WR 2721 protected mice from the lethality of cyclophosphamide by a factor of only 1.2 whereas protection from melphalan toxicity was more dramatic with a dose modifying factor of 1.6. In chemotherapy studies of established M5076 ovarian tumor, the combination of WR 2721 plus cyclophosphamide was equivalent in activity to cyclophosphamide alone. WR 2721 did not modify the antitumor activity of melphalan in early Lewis lung carcinoma but did decrease the antileukemic effects of this agent by a factor of 2.6 indicating tumor protection greater than host protection in the leukemia. The antitumor activity of the DNA binding agents etoposide (VP16--213) and mitoxantrone against systemic P388 leukemia was not diminished by WR 2721, while a substantial increase in host toxicity was noted for the combinations. The protective effects of WR 2721 against radiation and drug damage were, therefore, not entirely selective for normal tissues. In some cases the degree of tumor protection can be similar to, or greater than, normal tissue protection.
Assuntos
Amifostina/uso terapêutico , Neoplasias Experimentais/terapia , Compostos Organotiofosforados/uso terapêutico , Animais , Ensaio de Unidades Formadoras de Colônias , Feminino , Leucemia P388/terapia , Neoplasias Pulmonares/tratamento farmacológico , Camundongos , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/radioterapiaRESUMO
The electron-affinic compounds misonidazole (MISO), metronidazole (MET), desmethylmisonidazole (DMM), and CB1954 were shown to enhance the activity of alkylating agents in M5076 ovarian tumor. MISO, MET, and DMM enhanced the antitumor activity of cyclophosphamide by factors of 1.7, 1.5, and 1.7, respectively. MIS, MET, and CB1954 enhanced the antitumor activity of melphalan by factors of 2.2, 2.4, and 1.8, respectively. MISO also enhanced the antitumor activity of mitomycin C by a factor of 2.0. MISO did not enhance the activity of chlorozotocin given as a single dose and only slightly enhanced the antitumor activity of this agent when the combination was given on a q4D x 3 schedule. MISO administered 1 hr prior to the antimetabolite 5-FU on a q7D x 3 schedule was no more effective than 5-FU alone against colon carcinoma 38. MISO given simultaneously with or 1 hr after 5-FU strongly inhibited the antitumor activity of 5-FU in this tumor. Data obtained in this study indicate that several radiation sensitizers including three nitroimidazoles and a dinitrobenzamide can enhance the antineoplastic activity of alkylating agents. The degree of enhancement in the M5076 tumor appears to be independent of the electron affinity of the sensitizer. Enhancement was observed with relatively ineffective as well as highly active alkylating agents.
Assuntos
Antineoplásicos/farmacologia , Neoplasias Experimentais/tratamento farmacológico , Radiossensibilizantes/farmacologia , Animais , Neoplasias do Colo/tratamento farmacológico , Quimioterapia Combinada , Feminino , Camundongos , Misonidazol/uso terapêutico , Neoplasias Ovarianas/tratamento farmacológicoRESUMO
Selective protection of (9R)-9-amino-9-deoxoerythromycin A allowed for elimination of the 12-hydroxyl group to afford a versatile 12,21-olefin intermediate. Further modifications of the intermediate led to the syntheses of (9R)-9-deoxo-9-(N,N-dimethylamino)-12,21-epoxyerythromycin B, (9R)-9-deoxo-9-(N,N-dimethylamino)-21-hydroxyerythromycin A, and (9R)-9-deoxo-9-(N,N-dimethylamino)-21-hydroxyerythromycin B. All three compounds retained antibacterial activity against several organisms normally susceptible to (9R)-9-deoxo-9-(N,N-dimethylamino)erythromycin A. However, the 21-hydroxylated erythromycin A analogue was weaker in potency than the corresponding erythromycin B congener and much weaker than the epoxy derivative. This suggests that while substitution of a polar functionality at C-21 does not abolish antibacterial activity, introduction of vicinal polar groups at both C-12 and C-21 may lead to reduction in potency. Nevertheless, these 21-functionalized derivatives of (9R)-erythromycylamine provide an entry into novel analogues of the important macrolide antibiotic erythromycin.
Assuntos
Bactérias/efeitos dos fármacos , Eritromicina/análogos & derivados , Eritromicina/síntese química , Eritromicina/farmacologia , Testes de Sensibilidade Microbiana , Relação Estrutura-AtividadeRESUMO
Several ring-contracted analogues of the antitumor agent etoposide have been prepared. The synthesis of the simple indanyl system 3 is described along with two bicyclic systems of general structure 4 prepared through a stereoselective allylation of the keto-ester 6. A cis-fused lactone analogue 5, which is isomeric with the etoposide aglycone, has been synthesized via a dialkylation of the indene-2-carboxylate anion. Regiochemical and stereochemical results of these alkylations are described. The cytotoxicity of these derivatives toward several tumor cell lines is described and generally follows the structure-activity relationships known for the agent podophyllotoxin (2).
Assuntos
Antineoplásicos/síntese química , Podofilotoxina/síntese química , Adenocarcinoma/tratamento farmacológico , Animais , Antineoplásicos/uso terapêutico , Carcinoma/tratamento farmacológico , Fenômenos Químicos , Química , Neoplasias do Colo/tratamento farmacológico , Etoposídeo/análogos & derivados , Etoposídeo/química , Etoposídeo/uso terapêutico , Humanos , Indanos/química , Indanos/uso terapêutico , Leucemia P388/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Camundongos , Estrutura Molecular , Podofilotoxina/análogos & derivados , Podofilotoxina/química , Podofilotoxina/uso terapêutico , Relação Estrutura-Atividade , Células Tumorais CultivadasRESUMO
Topsentin, a bis(indolyl)imidazole marine natural product, inhibited the proliferation of cultured human and murine tumor cells at micromolar concentrations (IC50 values ranged from 4 to 40 microM) and was active against in vivo P388 leukemia (%T/C = 137, 150 mg/kg, QD1-5) and B16 melanoma (%T/C = 144, 37.5 mg/kg, QD1-9) tumors. Effects of 30 microM topsentin (1-hr exposures) on incorporation of radiolabeled precursors by P388 cells indicated inhibition of DNA synthesis (91%) and to a lesser extent RNA synthesis (57%), whereas synthesis of protein was unaffected (0%). Fluorescence spectral changes and competitive binding experiments with ethidium bromide indicated that topsentin interacted with DNA. No evidence for intercalation was observed in DNA unwinding studies, but competitive binding experiments with Hoechst 33342 and CC-1065 indicated that topsentin bound to DNA in the minor groove.
Assuntos
Antineoplásicos/farmacologia , Imidazóis/farmacologia , Indóis/farmacologia , Animais , Ligação Competitiva , Divisão Celular/efeitos dos fármacos , DNA/metabolismo , Humanos , Leucemia P388/tratamento farmacológico , Leucemia P388/patologia , Substâncias Macromoleculares , Melanoma Experimental/tratamento farmacológico , Melanoma Experimental/patologia , Espectrometria de Fluorescência , Células Tumorais CultivadasRESUMO
The radioprotective effect of 5-thio-D-glucose on mouse skin was studied. Intraperitoneal injection of A/J mice with 1.5 g/kg of 5-thio-D-glucose 2 hr prior to X irradiation of the foot reduced early foot skin damage through Day 40 postirradiation by a dose modification factor of 1.3 +/- 0.1. Similarly, late foot deformity during Days 60-90 postirradiation was reduced by a factor of 1.2 +/- 0.1. The radioprotective effect of 5-thio-D-glucose was also compared with that of WR-2721, an aminothiol radioprotector, in CDF1 mice. An intraperitoneal injection of 1.5 g/kg of 5-thio-D-glucose reduced early radiation-induced skin damage by a dose modification factor of 1.2 +/- 0.1 as compared to that of 1.5 +/- 0.2 by 0.65 g/kg of WR-2721 in this strain of mice. 5-Thio-D-glucose is also known to specifically kill and radiosensitize hypoxic tumor cells. Consequently, this drug may be a useful radiotherapy adjuvant, reducing normal tissue damage and enhancing tumor control by minimizing hypoxic protection.
Assuntos
Glucose/análogos & derivados , Protetores contra Radiação/farmacologia , Pele/efeitos dos fármacos , Amifostina/farmacologia , Animais , Relação Dose-Resposta à Radiação , Feminino , Deformidades Adquiridas do Pé/etiologia , Glucose/farmacologia , Injeções Intraperitoneais , Masculino , Camundongos , Lesões por Radiação/etiologia , Pele/efeitos da radiação , Fatores de TempoRESUMO
Capabilities are reported of di- and higher sulfides (RSnR') terminated by sulfinate functions [-S(O)O-] for protecting mice against otherwise lethal effects of ionizing radiation. With the use of congeners, structure-activity correlations are developed for the effects of esterification of the sulfinate function, of changing the length of the chain of sulfur atoms, of reduction to a mercapto sulfinate, and of changing the substituents R and R' to chiral and other types of groups. Neither a trisulfide nor a sulfinate by itself was significantly radioprotective. The key requirement for radio-protection in the series appears to be the presence of a sulfur function (-Sn-) from which a thiol can be engendered by a neighboring-group effect of an electron-donating group; sulfoxide functions may afford alternatives to sulfinate functions as such neighboring groups. The relevance of structure-activity relations to the chemical and biological mechanisms involved in the radioprotective activities is discussed.
Assuntos
Protetores contra Radiação , Sulfetos , Animais , Dissulfetos , Esquema de Medicação , Feminino , Camundongos , Veículos Farmacêuticos , Protetores contra Radiação/administração & dosagem , Relação Estrutura-AtividadeRESUMO
Novel analogs of (9R)-9-deoxo-9-(N,N-dimethylamino)erythromycin A bearing N-alkylamino substituents at the C-21 position were synthesized. These compounds retained antibacterial activity. The C-21, N,N-dimethylamino analog showed a modest improvement in activity against some Gram-negative bacteria.
Assuntos
Eritromicina/análogos & derivados , Bactérias/efeitos dos fármacos , Eritromicina/síntese química , Eritromicina/farmacologia , Relação Estrutura-AtividadeRESUMO
Several novel tiacumicin derivatives containing bromine have been produced by the addition of inorganic bromine to the fermentation both of Dactylosporangium aurantiacum subsp, hamdenensis. Structures were elucidated employing mass spectrometry and NMR spectroscopy. Antibacterial activity of the bromotiacumicins is comparable to that of the parent compounds.
Assuntos
Actinomycetales/metabolismo , Antibacterianos/biossíntese , Antibacterianos/química , Antibacterianos/farmacologia , Bromo , Fermentação , MacrolídeosRESUMO
Two novel triterpene sulfates have been isolated from Fusarium compactum by bioactivity-directed fractionation using an assay which measures the inhibition of proteolytic activity of rhinovirus 3C protease on a fluorogenic peptide substrate. The compounds were purified by countercurrent and reverse phase chromatographies. NMR, MS, UV and IR studies revealed two triterpene sulfates, uncommon metabolites of terrestrial fungi.
Assuntos
Colestenos/isolamento & purificação , Inibidores de Proteases/isolamento & purificação , Triterpenos/isolamento & purificação , Colestenos/química , Colestenos/farmacologia , Fermentação , Fusarium , Humanos , Espectroscopia de Ressonância Magnética , Testes de Sensibilidade Microbiana , Inibidores de Proteases/química , Inibidores de Proteases/farmacologia , Estereoisomerismo , Triterpenos/química , Triterpenos/farmacologiaRESUMO
The novel calcineurin inhibitor, dibefurin, has been isolated from the fungal culture AB 1650I-759. The isolation was bioactivity-directed fractionation using an assay which measures the phosphatase activity of calcineurin. The compound was purified by countercurrent, reverse phase and gel filtration chromatographies. Several studies, including crystallographic, NMR and MS, revealed that dibefurin is a novel dimeric compound of a unique structural type.
Assuntos
Benzofuranos/farmacologia , Proteínas de Ligação a Calmodulina/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Fungos/metabolismo , Fosfoproteínas Fosfatases/antagonistas & inibidores , Benzofuranos/química , Calcineurina , Cromatografia em Gel , Cristalografia por Raios X , Inibidores Enzimáticos/química , Fermentação , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Espectroscopia de Infravermelho com Transformada de FourierRESUMO
DNA topoisomerases, found in all prokaryotic and eukaryotic cells, play a key role in controlling the topological state of DNA. Quinolone antibacterial agents have been shown to be inhibitors of DNA gyrase, a bacterial topoisomerase II enzyme. The eukaryotic topoisomerase II is the target of various cytotoxic agents such as adriamycin and etoposide. Recently, several quinolones having C-8 fluoro and C-8 chloro substituents have been found to have cytotoxic activities and to interact with mammalian topoisomerase II. In searching for an antitumour agent of the quinolone class, we identified several quinolones having excellent in vitro cytotoxic activity. A-74932 also possesses good activity in vivo against both systemic tumour and subcutaneously implanted murine solid tumours as well as human tumour xenografts. The chemical synthesis as well as biological properties of A-74932 are described.